9
Participants
Start Date
December 15, 2021
Primary Completion Date
October 6, 2023
Study Completion Date
October 6, 2023
PN-101
"PN-101: Mitochondria isolated from Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells.~3 or 6 subjects are enrolled in each dose group in line with the traditional 3+3 rule-based method, and the investigator intravenously administers a single-dose of the investigational product according to the planned dose."
Seoul National University Hospital, Seoul
Soonchunhyang University Seoul Hospital, Seoul
Hanyang University Seoul Hospital, Seoul
Lead Sponsor
Paean Biotechnology Inc.
INDUSTRY